CADTH reimbursement recommendation : Hoffmann-La Roche Ltd. : indication: bleeding prevention, hemophilia A (congenital factor VIII deficiency). Emicizumab (Hemlibra)

CADTH reimbursement recommendation Hoffmann-La Roche Ltd. : indication: bleeding prevention, hemophilia A (congenital factor VIII deficiency). Emicizumab (Hemlibra)

Bibliographic Details
Main Author: Canadian Agency for Drugs and Technologies in Health (author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health, author, issuing body (author)
Format: eBook
Language:Inglés
Published: Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health 2020.
Subjects:
Economic development projects > Cost effectiveness.
See on Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820283906719
Description
Physical Description:1 online resource (10 pages)

Similar Items